5
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Differential Diagnosis

The Challenge of Chronic Fatigue

Pages 17-31 | Published online: 04 Dec 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yoshitsugi Hokama, C. Whang, K. F. Chun, C. Suma, N. Higa, B. F. W. Or, A. Cocchetto & G. Kansky. (2003) Chronic Phase Lipids in Sera of Several Chronic Diseases Reacting with MAB–CTX (Antibody to Ciguatoxin). Journal of Toxicology: Toxin Reviews 22:4, pages 547-554.
Read now

Articles from other publishers (2)

Yoshitsugi Hokama, Cara Empey‐Campora, Cynthia Hara, Nicole Higa, Nathaniel Siu, Rachael Lau, Tina Kuribayashi & Kenichi Yabusaki. (2008) Acute phase phospholipids related to the cardiolipin of mitochondria in the sera of patients with chronic fatigue syndrome (CFS), chronic ciguatera fish poisoning (CCFP), and other diseases attributed to chemicals, Gulf War, and marine toxins. Journal of Clinical Laboratory Analysis 22:2, pages 99-105.
Crossref
Y. Hokama, G.A. Uto, N.A. Palafox, D. Enlander, E. Jordan & A. Cocchetto. (2003) Chronic phase lipids in sera of chronic fatigue syndrome (CFS), chronic ciguatera fish poisoning (CCFP), hepatitis B, and cancer with antigenic epitope resembling ciguatoxin, as assessed with MAb‐CTX. Journal of Clinical Laboratory Analysis 17:4, pages 132-139.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.